Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer

Clinical trial NCT01298011 · COMPLETED

Trial details

NCT number: NCT01298011
Sponsor: Pancreatic Cancer Research Team
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Pancreatic Cancer

Start date: 2011-05-01
Primary completion: 2013-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.